Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study
Viruses · 29.03.2023 · 15 (4) · 879
DOI: 10.3390/v15040879 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Viruses, online erschienen am 29.03.2023. Verfasst von Vanessa Costa Alves Galúcio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Amazon Foundation for Research Support (FAPESPA), the Secretary of Science, Technology, and Higher, Professional, and Technological Education (SECTET), the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil (CAPES).
Abstract (Originalsprache)
Long COVID affects many individuals following acute coronavirus disease 2019 (COVID-19), and hematological changes can persist after the acute COVID-19 phase. This study aimed to evaluate these hematological laboratory markers, linking them to clinical findings and long-term outcomes in patients with long COVID. This cross-sectional study selected participants from a ‘long COVID’ clinical care program in the Amazon region. Clinical data and baseline demographics were obtained, and blood samples were collected to quantify erythrogram-, leukogram-, and plateletgram-related markers. Long COVID was reported for up to 985 days. Patients hospitalized in the acute phase had higher mean red/white blood cell, platelet, and plateletcrit levels and red blood cell distribution width. Furthermore, hematimetric parameters were higher in shorter periods of long COVID than in longer periods. Patients with more than six concomitant long COVID symptoms had a higher white blood cell count, a shorter prothrombin time (PT), and increased PT activity. Our results indicate there may be a compensatory mechanism for erythrogram-related markers within 985 days of long COVID. Increased levels of leukogram-related markers and coagulation activity were observed in the worst long COVID groups, indicating an exacerbated response after the acute disturbance, which is uncertain and requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil.
- School of Medicine, São Paulo University (USP), São Paulo 01246903, Brazil.
- Tropical Medicine Center, Federal University of Pará (UFPA), Belém 66055-240, Brazil.
ORCID-Profile: Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão
Förderung
- the Amazon Foundation for Research Support (FAPESPA)
- the Secretary of Science, Technology, and Higher, Professional, and Technological Education (SECTET)
- the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil (CAPES)
- the Conselho Nacional de Desenvolvimento Científico e Tecnológico—Brazil
Zitieren
APA
Galúcio, V. C. A., Menezes, D. C., Lima, P. D. L., Palácios, V. R. D. C. M., Vasconcelos, P. F. D. C., Quaresma, J. A. S., & Falcão, L. F. M. (2023). Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study. Viruses, 15(4), 879. https://doi.org/10.3390/v15040879
Vancouver
Galúcio VCA, Menezes DC, Lima PDL, Palácios VRDCM, Vasconcelos PFDC, Quaresma JAS, et al. Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study. Viruses. 2023;15(4):879. doi:10.3390/v15040879
BibTeX
@article{Galcio2023,
author = {Galúcio, Vanessa Costa Alves and Menezes, Daniel Carvalho de and Lima, Patrícia Danielle Lima de and Palácios, Vera Regina da Cunha Menezes and Vasconcelos, Pedro Fernando da Costa and Quaresma, Juarez Antônio Simões and Falcão, Luiz Fábio Magno},
title = {Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study},
journal = {Viruses},
year = {2023},
volume = {15},
number = {4},
pages = {879},
doi = {10.3390/v15040879}
}
EUVIMED